Antithyroid Drug Treatment in Graves’ Disease
نویسندگان
چکیده
منابع مشابه
Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence
Graves' disease (GD) is the most common cause of hyperthyroidism worldwide. Current therapeutic options for GD include antithyroid drugs (ATD), radioactive iodine, and thyroidectomy. ATD treatment is generally well accepted by patients and clinicians due to some advantages including normalizing thyroid function in a short time, hardly causing hypothyroidism, and ameliorating immune disorder whi...
متن کاملThe thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment
BACKGROUND We previously reported that depressive personality (the scores of hypochondriasis, depression and psychasthenia determined by the Minnesota Multiphasic Personality Inventory (MMPI)) and daily hassles of Graves' disease (GD) patients treated long trem with antithyroid drug (ATD) were significantly higher in a relapsed group than in a remitted group, even in the euthyroid state. The pr...
متن کاملGraves' disease in childhood: advances in management with antithyroid drug therapy.
Graves' disease is the most common cause of hyperthyroidism in children. Antithyroid drug (ATD) treatment is recommended as the initial treatment, leading to a marked improvement in most symptoms within 1 month of treatment initiation. Remission is achieved in 30% of children after a first course of ATD. Alternative treatments, such as radioactive iodine or thyroidectomy, are considered in case...
متن کاملA second course of antithyroid drug therapy for recurrent Graves' disease: an experience in endocrine practice
OBJECTIVE There are scarce reports regarding the prognosis of a second course of antithyroid drug (ATD) therapy on recurrent Graves' disease (GD). The aim of this study was to assess the long-term remission rate after a second ATD therapy and verify significant clinical predictors of a remission. DESIGN A prospective randomized clinical trial with long-term follow-up was conducted to evaluate...
متن کاملCan bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?
CONTEXT Hyperthyroidism can lead to reduced bone mineral density (BMD) and increased fracture risk particularly in postmenopausal women, but the mechanism behind is still unclear. OBJECTIVE Prospective examination of the influence of thyroid hormones and/or thyroid autoantibodies on BMD in premenopause. DESIGN We have examined 32 premenopausal women with untreated active Graves' disease fro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Endocrinology and Metabolism
سال: 2021
ISSN: 2093-596X,2093-5978
DOI: 10.3803/enm.2021.1070